Optimizing genome-wide mutation analysis of chromosomes and genes

Abstract

A method of genome-wide testing of gene copy number at the genetically most important loci to determine whether the gene and/or its selected larger surrounding chromosome region is rearranged to result in an unbalanced abnormality in one or more subjects, said method including selecting multiple gene loci of said DNAs to be examined in said test, conducting said test, and comparing the number of copies at each locus tested by quantification of total gene target number to determine the relative, number of each polymorphic sequence detected to assure that each important tested sequence is distinguished from the other alleles at the same locus. A method of detecting the highest number of abnormal patients possible based upon the number of test sites available in a protocol including selecting the most common genetic disease-causing mutations in a population by frequency, selecting and identifying the most common mutations in each by frequencies, multiplying the two frequencies together to get a frequency product which is the frequency of each mutation in the population, and ordering the frequency products beginning with the most common to prioritize which are the most common to detect the largest number of genetic abnormalities possible per test. Depending upon the stage of the life cycle, both of the methods can be done together or in sequence.

Description

CROSS REFERENCE TO RELATED APPLICATIONS [0001] This application claims the priority of U.S. Provisional Application Ser. No. 60 / 161857 filed Oct. 27, 1999 and U.S. Provisional Application Ser. No. 60 / 317,007 filed Sep. 4, 2001 entitled “Genome-Wide Aneuploid Analysis of Chromosomes and Genes” by QPCR the whole of which is hereby incorporated by reference herein.BACKGROUND OF THE INVENTION [0002] Since the early 1970's when routine chromosome banding was developed, Giemsa-banded chromosome analysis has been applied to diagnosing chromosome abnormalities in fetuses, abnormal children, adolescents, and adults, in both normal and neoplastic tissues. Giemsa-banded karyotypes will detect abnormal chromosomes in about 644 newborns among every 100,000 births (Lebo et al, 1992). Banded chromosome analysis is time-consuming and requires considerable training and expertise from growing the cells and preparing slides of well separated, banded chromosomes, to recognizing and analyzing spreads of...

AI Technical Summary

Benefits of technology

[0022] This invention increases the proportion of informative tests for whole or partial chromosome aneuploidy or gene aneuploidy over current methods by using quantitative gene region analysis to (1) unambiguously characterize aneuploidy of chromosomes 13, 18, 21, X and Y that result in a majority of the phenotypic chromosome abnormalities in fetuses and newborns, (2) expand testing to detect other microscopic or submicroscopic partial chromosome imbalances in 30 additional chromosome regions, (3) test genetic diseases resulting from unique gene aneuploidy including, and (4) to readily add testing for the most common gene mutations in the patient's ancestral population. Detecting the second category of gene imbalance will increase the frequency of prenatal chromosome abnormalities that are detected rapidly in Category 1 from 95% of phenotypically significant chromosome abnormalities in newborns (Lebo et al, 1992) to 98%, while also adding category (3) will provide a total pickup of 102% of the number detected by current Giemsa-banded chromosome analysis. This includes testing for the 7 common deleted dystrophin gene regions to detect about 60% of the dystrophin gene mutations in affected male fetuses found at a frequency of about 1 in 20,000 live births in families with no prior family history with the ability to determine these results from a direct fetal cell sample without cell culture, DNA analysis is predicted to be more clear-cut than the rapid screening Combined interphase in situ hybridization test and when sufficiently reliable is likely to replace karyotyping as the screening test of choice. The fourth t

Problems solved by technology

Unbalanced gametes and zygotes result from whole chromosome aneuploidy (abnormal number), unbalanced translocations (unbalanced reciproc

Images